Skip to main content

Advertisement

Table 1 The PMTCT options and interventions for the mother and baby

From: Early infant diagnosis of HIV infection using DNA-PCR at a referral center: an 8 years retrospective analysis

  Treatment (for CD4 count <350 cells/mm3) Prophylaxis (for CD4 count >350 cells/mm3) Infant receives
Option A Triple ARVs starting as soon as diagnosed, continued for life Antepartum: AZT starting as early as 14 weeks gestation Intrapartum: at onset of labour, single-dose NVP and first dose of AZT/3TC
Postpartum: daily AZT/3TC through 7 days postpartum
Daily NVP from birth until 1 week after cessation of all breastfeeding; or, if not breastfeeding or if mother is on treatment, through age 4–6 weeks
Option B Triple ARVs starting as soon as diagnosed, continued for life Triple ARVs starting as early as 14 weeks gestation and continued intrapartum andthrough childbirth if not breastfeeding or until 1 week after cessation of all breastfeeding Daily NVP or AZT from birththrough age 4–6 weeks regardless of infant feeding method
Option B+ Triple ARVs starting as soon as diagnosed, continued for life Triple ARVs starting as soon as diagnosed, continued for life Daily NVP or AZT from birth through age 4–6 weeks regardless of infant feeding method